Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2011; 17(36): 4113-4117
Published online Sep 28, 2011. doi: 10.3748/wjg.v17.i36.4113
Table 2 Relationship between -1195 G/C COX-2 polymorphism and clinical data of patients with pancreatic cancer n (%)
GroupG+ allele(GA and GG)(n = 39)P valueG- allele(AA)(n = 46)P value
Age< 6520 (51.3)NS19 (41.3)NS
≥ 6519 (48.7)27 (58.7)
GenderMale18 (46.2)NS23 (50.0)NS
Female21 (53.8)23 (50.0)
Tumor size ≤ 3 cm21 (53.8)NS13 (28.3)P < 0.05
> 3 cm18 (46.2)33 (71.7)
TumorG1 + G221 (53.8)NS27 (58.7)NS
DifferentiationG317 (43.8)18 (39.2)
Lymph nodeAbsent23 (58.9)NS23 (50.0)NS
MetastasesPresent16 (41.1)23 (50.5)
Weight loss< 10 %19 (48.7NS25 (54.4)NS
≥ 10%20 (51.3)21 (45.6)
SmokingYes21 (53.8)NS19 (41.3)NS
No18 (46.2)27 (58.7)
CA19-9< 37 U/mL10 (25.6)NS13 (28.3)NS
≥ 37 U/mL29 (74.4)33 (71.7)